Mucinous Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Mucinous Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study) [Phase 2]
A Phase 2 clinical trial (HI-MOC) evaluating secondary cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy for recur…
-
CLINICAL_TRIALS research · 2025-10-22Clinical Trial Update: A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib [Phase 2]
A Phase 2 trial of Avutometinib (VS-6766) in combination with Defactinib is recruiting for several gynecologic cancers, including endometria…
-
CLINICAL_TRIALS trial_result · 2022-12-29Clinical Trial Update: Bevacizumab Plus Modiifed FOLFIRINOX in Ovarian, Fallopian Tube, or Primary Peritoneal Mucinous Carcinoma [Phase 2]
Phase 2 clinical trial evaluating bevacizumab with modified FOLFIRINOX for mucinous ovarian, fallopian tube, or primary peritoneal cancers.
-
CLINICAL_TRIALS trial_result · 2015-12-01Clinical Trial Update: Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma [Phase 2]
Phase 2 trial evaluating erlotinib in combination with carboplatin and paclitaxel in ovarian and related cancers. The study has completed an…